Pages that link to "Q56699816"
Jump to navigation
Jump to search
The following pages link to "Endgame" Issues for the Global Polio Eradication Initiative (Q56699816):
Displaying 26 items.
- Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001 (Q24559785) (← links)
- Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993 (Q24682487) (← links)
- The effect of azithromycin on ivermectin pharmacokinetics--a population pharmacokinetic model analysis (Q28472672) (← links)
- Limited duration of vaccine poliovirus and other enterovirus excretion among human immunodeficiency virus infected children in Kenya (Q33495786) (← links)
- Synthesizing epidemiological and economic optima for control of immunizing infections (Q35180717) (← links)
- Global health goals: lessons from the worldwide effort to eradicate poliomyelitis (Q35296220) (← links)
- Risk management in a polio-free world (Q36690337) (← links)
- Retrospective Analysis of a Local Cessation of Vaccination against Poliomyelitis: a Possible Scenario for the Future (Q37060273) (← links)
- Microbe hunting in the 21st century (Q37068320) (← links)
- Vaccine-associated paralytic poliomyelitis: a case report of flaccid monoparesis after oral polio vaccine (Q37220421) (← links)
- Emergence of vaccine-derived polioviruses, Democratic Republic of Congo, 2004-2011. (Q37261927) (← links)
- Multiplex PCR method for identifying recombinant vaccine-related polioviruses. (Q37511244) (← links)
- Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future (Q38637663) (← links)
- Effect on seroprevalence of anti-poliovirus antibodies and on vaccination coverage of the implementation of a DTwP-IPV-Hib vaccination programme in a South American city (Q39939710) (← links)
- The costs of future polio risk management policies. (Q40258086) (← links)
- Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa (Q40269934) (← links)
- Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. (Q44890455) (← links)
- Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children. (Q45103186) (← links)
- Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells (Q47435116) (← links)
- Genomic analysis of recombinant sabin clinical isolates (Q48092623) (← links)
- Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. (Q50183859) (← links)
- Baseline patterns of bone scintigraphy in patients with established post-poliomyelitis paralysis (Q51626944) (← links)
- Eradication of poliomyelitis (Q77719565) (← links)
- Challenges in the final stage of polio eradication (Q79985512) (← links)
- Polio eradication-rethinking the endpoint of the end game (Q80033116) (← links)
- The risks, costs, and benefits of possible future global policies for managing polioviruses (Q81358171) (← links)